Box 2
Contains 118 Results:
Aaronson, Bernard S. "LSD: Experimental Findings," Parapsychology. (photocopy), June 1967
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.
Aaronson, Bernard S. Some Hypnotic Analogues to the Psychedelic State. (print out), undated
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.
Abraham, David Henry. LSD-25: Differentiable Sensitivities in Human Beings. (print out), January 21, 1980
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.
Abramson, Harold A. "Lysergic Acid Diethlamide (LSD-25): III. As an Adjunct to Pyschotherapy with Elimination of Fear of Homosexuality," The Journal of Psychology. 35 (reprint), 1955
Handwritten notes on front page.
Abramson, H. A. "Discussion Second Symposium," Neuro-Psychopharmacology. (reprint), 1956
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.
Abramson, Harold A., Andre Rolo, and Jeanne Stache. "Lysergic Acid Diethylamide (LSD-25) Antagonists: Chlorpromazine," Journal of Neuropsychiatry. Vol. 1, No. 6 (reprint), July - August 1960
Handwritten annotations on front page.
Abramson, H. A., B. Sklarofsky, M. O. Baron, and H. H. Gettner. "Lysergic Acid Diethylamide (LSD-25) Antagonists," A. M. A. Archives of Neurology and Psychiatry. Vol. 77 (reprint), April 1957
Two copies. Second copy has hole punches.
Abramson, Harold A. and Bernard Sklarofsky. "Lysergic Acid Diethylamide (LSD-25) Antagonists," A. M. A. Archives of General Psychiatry. Vol. 2 (reprint), January 1960
Two copies.
Abramson, H. A. and Evans, L. T. "Lysergic Acid Diethylamide (LSD 25): II. Psychobiological Effects on the Siamese Fighting Fish," Science. Vol. 120, No. 3128 (reprint), December 10, 1954
Hole punches and annotations are present.
Abramson, H. A., M. E. Jarvik, and M. W. Hirsch. "Lysergic Acid Diethylamide (LSD-25): VII. Effect Upon Two Measures of Motor Performance," The Journal of Psychology, 39, 1955. (reprint), 1955
Two copies.
Abramson, H. A. , S. E. Waxenberg, A. Levine, M. R. Kaufman, and C. Kornetsky. "Lysergic Acid Diethylamide (LSD-25) XIII. Effect on Bender-Gestalt Test Performance," The Journal of Psychology. 40 (reprint), 1955
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.
Abramson, Harold A. and Murray E. Jarvik. "Lysergic Acid Diethylamide (LSD-25): IX. Effect on Snails," The Journal of Psychology. 40 (reprint), 1955
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.
Abramson, H. A., M. E. Jarvik, and M. W. Hirsch. "Lysergic Acid Diethylamide (LSD-25): X. Effect on Reaction Time to Auditory andVisual Stimuli," The Journal of Psychology. 50 (reprint), 1955
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.
Abramson, H. A., C. Kornetsky, M. E. Jarvik, M. R. Kaufman, and M. W. Ferguson. "Lysergic Acid Diethylamide (LSD-25): XI. Content Analysis of Clinical Reactions," The Journal of Psychology. 40 (reprint), 1955
Underlining and annotations throughout.
Abramson, H. A., M. E. Jarvik, A. Levine, M. R. Kaufman, and M. W. Hirsch. "Lysergic Acid Diethylamide (LSD-25): XV. The Effects Produced by Substitution of a Tap Water Placebo," The Journal of Psychology. 40 (reprint), 1955
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.
Abramson, H. A., M. E. Jarvik, M. H. Gorin, and M. W. Hirsch. "Lysergic Acid Diethylamide (LSD-25): XVII. Tolerance Development and its Relationship to a Theory of Psychosis," The Journal of Psychology. 41 (reprint), 1956
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.
Abramson, Harold A. "Lysergic Acid Diethylamide (LSD-25): XXII. Effect on Transference," The Journal of Psychology. 42 (reprint), 1956
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.
Abramson, Harold A. "Lysergic Acid Diethylamide (LSD-25): XIX. As an Adjunct to Brief Psychotherapy, with Special Reference to Ego Enhancement," The Journal of Psychology. 41 (reprint), 1956
Handwritten annotations throughout.
Abramson, Harold A. "Lysergic Acid Diethylamide (LSD-25): XXII. Effect on Transference," The Journal of Psychology. 42 (reprint), 1956
Handwritten annotations throughout.
Abramson, H. A. "Lysergic Acid Diethylamide (LSD-25): XXIX. The Response Index as a Measure of Threshold Activity of Psychotropic Drugs in Man," The Journal of Psychology. 48 (reprint), 1959
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.
Abramson, H. A. "Lysergic Acid Diethylamide (LSD-25): XXX. The Questionnaire Technique with Notes on its Use," The Journal of Psychology. 49 (reprint), 1960
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.
Abramson, H. A., and A. Rolo. "Lysergic Acid Diethylamide (LSD-25): XXXVIII. Comparison with Action of Methysergide and Psilocybin on Test Subjects," The Journal of Asthma Research. Vol. 2, No. 4 (preprint), June 1965
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.
Abramson, H. A. "Lysergic Acid Diethylamide (LSD-25): XXX. The Questionnaire Technique with Notes on its Use," The Journal of Psychology. 49 (reprint), 1960
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.
Abramson, H. A., M. E. Jarvik, and M. W. Hirsch. "Lysergic Acid Diethylamide (LSD-25): X. Effect on Reaction Time to Auditory and Visual Stimuli," The Journal of Psychology. 40 (reprint), 1955
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.
Abramson, H. A., A. Rolo, B. Skylarofsky, and J. Stache. "Production of Cross-Tolerance to Psychosis Producing Doses of Lysergic Acid Diethylamide and Psilocybin," The Journal of Psychology. 49 (reprint), 1960
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.